(Q38920636)

7 September 2017

1 reference

title

Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis (English)

1 reference

7 September 2017

1 reference

cardiovascular disease

1 reference

1 reference

7

Adrian Covic

1 reference

7 September 2017

3

1 reference

7 September 2017

4

Gamze Aslan

1 reference

7 September 2017

2

Yalcin Solak

1 reference

7 September 2017

1

Mehmet Kanbay

1 reference

7 September 2017

Baris Afsar

5

1 reference

7 September 2017

Dilek Yazici

series ordinal

6

1 reference

7 September 2017

language of work or name

1 reference

6 August 2016

1 reference

International Urology and Nephrology

7 September 2017

published in

1 reference

7 September 2017

volume

48

1 reference

7 September 2017

issue

12

1 reference

7 September 2017

page(s)

2029-2042

1 reference

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Renal elimination of sclerostin increases with declining kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Sclerostin: Another vascular calcification inhibitor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Sclerostin as a new key player in arteriovenous fistula calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Serum sclerostin levels, arteriovenous fistula calcification and 2-years all-cause mortality in prevalent hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Sclerostin quo vadis? - is this a useful long-term mortality parameter in prevalent hemodialysis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Serum sclerostin is an independent predictor of mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Uremic toxicity and sclerostin in chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Adynamic bone disease: from bone to vessels in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-016-1387-8

Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study

21 January 2018

1 reference

12 December 2020

Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?

1 reference

12 December 2020

Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients

1 reference

12 December 2020

Can we compare serum sclerostin results obtained with different assays in hemodialysis patients?

1 reference

12 December 2020

High Serum Sclerostin Levels Are Associated with a Better Outcome in Haemodialysis Patients

1 reference

12 December 2020

Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification

1 reference

12 December 2020

Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients

1 reference

12 December 2020

Sclerostin: just one more player in renal bone disease?

1 reference

12 December 2020

High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study

1 reference

12 December 2020

Determinants of serum sclerostin in healthy pre- and postmenopausal women

1 reference

12 December 2020

Novel therapies for osteoporosis

1 reference

12 December 2020

10.1007/S11255-016-1387-8

Identifiers

DOI

1 reference

release_7h4txxl6n5b5ve4mphrwtlrmqe

7 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7h4txxl6n5b5ve4mphrwtlrmqe

24 November 2022

mapped directly with Wikidata item

1 reference